SEC Form 4 · accession 0001179110-17-005277
REATA PHARMACEUTICALS INC · RETA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
AbbVie Inc.
10% Owner
Period of report
Mar 28, 2017
Accepted (ET)
Mar 30, 2017 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Mar 28, 2017 | S | 450,000 | $22.50 | D | 1,190,473 | D |
Table II — derivative securities
No Table II lines on this filing.